Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services tags : Therapeutics save search
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.93%
H: 0.36%
C: -0.05%
rare disease collaboration therapeutics therapy
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.0%
H: 1.41%
C: -0.26%
collaboration therapeutics therapy
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
XCUR 4 | $0.5825 0.64% 0.64% 22K
|
Commercial Services
|
| O: 1.1%
H: 1.82%
C: 1.76%
hepatitis patent license treatment therapeutics agreement
Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing Demand for Personalized Medicine
Published: 2024-01-16 (Crawled : 15:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.69%
H: 0.46%
C: -0.08%
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: -1.58%
H: 0.17%
C: -0.83%
CTLT | $55.48 -0.57% -0.4% 1.6M
|
Health Technology
|
| O: -0.63%
H: 0.97%
C: 0.82%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -1.27%
H: 1.62%
C: -0.33%
growing therapeutics advanced market
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
Published: 2023-10-11 (Crawled : 17:00) - globenewswire.com
PMVP | $1.61 -0.62% -0.62% 480K
|
Commercial Services
|
| O: 0.47%
H: 1.49%
C: -26.36%
pc1458 conference cancer international pharmaceuticals therapeutics molecular
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-09-20 (Crawled : 20:00) - globenewswire.com
PMVP | $1.61 -0.62% -0.62% 480K
|
Commercial Services
|
| O: -1.06%
H: 5.05%
C: 2.52%
pc1458 conference cancer international pharmaceuticals therapeutics molecular
Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors
Published: 2023-06-22 (Crawled : 20:00) - globenewswire.com
ACRV P | $9.405 -10.77% -12.07% 630K
|
|
| O: 0.93%
H: 6.38%
C: 5.0%
PMVP | $1.61 -0.62% -0.62% 480K
|
Commercial Services
|
| O: -1.54%
H: 2.61%
C: 1.92%
biopharma therapeutics
Pear Therapeutics Files For Bankruptcy As CEO Blames Shortfalls … – Forbes
Published: 2023-04-07 (Crawled : 23:00) - spacfeed.com
SHRG 4 | $0.002 84.21% 66K
|
Information
| Email alert
Add to watchlist
SRT | $4.42 1.14% 0.0% 0
|
Commercial Services
| Email alert
Add to watchlist
ceo therapeutics
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
Published: 2023-02-15 (Crawled : 23:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: -1.12%
H: 1.83%
C: 1.04%
collaboration therapeutics therapy
Tallac Therapeutics Announces First Patient Dosed with TAC-001, a First-in-Class Toll-like Receptor 9 Agonist Antibody Conjugate, in a Phase 1/2 Study for Patients with Advanced Solid Tumors
Published: 2022-07-28 (Crawled : 14:20) - biospace.com/
ALXO M | $15.6 -0.89% -0.9% 480K
|
Commercial Services
|
| O: -0.33%
H: 0.25%
C: -7.46%
tac-001 antibody therapeutics study
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
Published: 2022-06-13 (Crawled : 13:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: -4.12%
H: 0.92%
C: -0.41%
therapeutics therapy
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
Published: 2022-05-09 (Crawled : 12:20) - biospace.com/
XCUR 4 | $0.5825 0.64% 0.64% 22K
|
Commercial Services
|
| O: -4.31%
H: 0.25%
C: -16.58%
conference therapeutics
Coya Therapeutics Appoints David Snyder as Chief Financial Officer and Chief Operating Officer
Published: 2022-03-30 (Crawled : 15:20) - biospace.com/
XCUR 4 | $0.5825 0.64% 0.64% 22K
|
Commercial Services
|
| O: 0.66%
H: 2.8%
C: -3.6%
therapeutics
iTeos Therapeutics Set to Join S&P SmallCap 600
Published: 2021-12-31 (Crawled : 00:20) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
| Email alert
Add to watchlist
CNC | $75.15 1.9% 0.0% 2.7M
|
Health Services
| Email alert
Add to watchlist
therapeutics set
Kazia Therapeutics to Present at LD Micro Invitational XI
Published: 2021-06-03 (Crawled : 12:00) - biospace.com/
SRAX | $0.19 5.26% 160
|
Commercial Services
|
| O: -1.11%
H: 2.61%
C: 0.0%
KZIA | $0.379 9.47% 8.65% 300K
|
Health Technology
|
| O: 0.81%
H: 0.81%
C: 0.3%
presentation therapeutics
Cara Therapeutics Set to Join S&P SmallCap 600
Published: 2021-04-05 (Crawled : 00:00) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: -0.3%
H: 0.6%
C: -0.06%
APH | $110.17 -0.64% 0.0% 3.7M
|
Electronic Technology
|
| O: -0.49%
H: 0.18%
C: -0.29%
therapeutics set
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.